Although the FDA does conduct some surveillance and inspections of these pharmacies, the day-to-day oversight happens at the state level, which means standards can vary from state to state
For patients with metabolic syndrome affecting multiple organ systems, retatrutide addresses more pathways simultaneously
Mitsuharu M, Hiroaki Y, Hitomi O, Kazunobu A, Tadahiro N, Sayuri N, et al
Based on the weekly injection schedule used in trials, missing one dose is unlikely to cause major disruption
Dosing and risk reduction Some researchers believe that slower dose escalation and lower maintenance doses may reduce the risk of severe GI complications
Mounjaro and Zepbound contain tirzepatide, a dual GIP/GLP-1 agonist, which causes slower gastric emptying than GLP-1 agonists